Outcome of intracerebral haemorrhage patients pre-treated with statins

European Journal of Neurology

Volumn 17, Issue 3, 2010, Pages 443-448

  Gomis, M ^a,b   Ois, A ^a   Rodriguez Campello A ^a   Cuadrado Godia, E ^a   Jimenez Conde J ^a   Subirana, I ^a   Davalos A ^b   Roquer, J ^a  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Intracerebral haemorrhage; Outcome; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN VENTRICLE; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; GLASGOW COMA SCALE; HEMATOMA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

AGE FACTORS; AGED; BRAIN; CEREBRAL HEMORRHAGE; FEMALE; HEMATOMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649157782     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02838.x     Document Type: Article

References (33)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001 344 : 1450 1460.
2. Labovitz DL, Halim A, Boden-Albala B, Hauser WA, Sacco RL. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks and hispanics. Neurology 2005 65 : 518 522. (Pubitemid 41170708)
3. Mendelow AD, Gregson BA, Fernandes HM, et al. STICH Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Hemorrahge (STICH): a randomised trial. Lancet 2005 365 : 387 397.
4. Mayer SA, Brun NC, Begtrup K, et al. FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008 358 : 2127 2137.
5. Lyden PD, Shuaib A, Lees KR, et al. for the CHANT Trial Investigators. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke 2007 38 : 2262 2269.
6. Wahlgren NG, Diez-Tejedor E, Teitelbaum J, et al. for the CLASS (Clormethiazole Acute Stroke Study) Study Group. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients. Stroke 2000 31 : 82 85.
7. Wahlgren NG, Ranasinha KW, Rosolacci T, et al. Clormethiazole acute stroke study (CLASS): results of a randomized controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 1999 30 : 21 28.
8. Okumura K, Iseki K, Wakugami K, et al. Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. Jpn Circ J 1999 63 : 53 58.
9. Segal AZ, Chiu RI, Eggleston-sexton PM, Beiser A, Greenberg SM. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 1999 18 : 185 193.
10. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke 1989 20 : 1460 1465.
11. Thrift AG, McNeil JJ, Forbes A, Donan GA. Risk factors for cerebral hemorrhage in the era of well controlled hipertensión. Melbourne Risk Factor Study (MERFS) Group. Stroke 1996 27 : 2020 2025.
12. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000 6 : 1004 1010.
13. Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003 53 : 743 751.
14. Martí-Fábregas J, Gomis M, Arboix A, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004 35 : 1117 1123.
15. McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002 33 : 2950 2956.
16. Seyfried D, Han Y, Lu D, Chen J, Bydon A, Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 2004 101 : 104 107.
17. Jung KH, Chu K, Jeong SW, et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 2004 35 : 1744 1749.
18. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996 27 : 1304 1305.
19. Hemphill JC III., Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001 32 : 891 897.
20. Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Guía para el diagnóstico y tratamiento del ictus. Barcelona: Prous Science, 2004.
21. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007 69 : 904 910.
22. Amarenco P, Bogousslavsky J, Callahan A III., et al. Stroke prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 355 : 549 559.
23. Juvela S. Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 1995 52 : 1193 1200.
24. Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 2008 8 : 6 12.
25. Naval NS, Abdelhak TA, Urrunaga N, Zeballos P, Mirski MA, Carhuapoma JR. An association of Prior Statin Use with Decreased perihematomal Edema. Neurocrit Care 2008 8 : 13 18.
26. FitzMaurice E, Wendell L, Snider R, et al. Effect of Statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008 39 : 2151 2154.
27. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D on behalf of the NASIS investigators. Prior use of statins improves outcome in patients with intracerebral hemorrhage. Stroke 2009 40 : 2581 2584.
28. Roquer J, Rodríguez-Campello A, Gomis M, Ois A, Munteis E, Böhm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 2005 65 : 1198 1202.
29. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006 6 : 358 370.
30. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 97 : 1129 1135.
31. Ponce J, Pérez de la Ossa N, Hurtado O, et al. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke 2008 39 : 1269 1275.
32. Castillo J, Dávalos A, Alvarez-Sabin J, et al. Molecular signatures of brain injury after cerebral hemorrhage. Neurology 2002 58 : 624 629.
33. Endres M, Laufs U. Discontinuation of statin treatment in stroke patients. Stroke 2006 37 : 2640 2643.